Search Options Stock News and Analysis from Schaeffer's

BREAKING NEWS: Stocks in Disarray Six Months Into 2022

About Us
Market News
Premium
Options 101
Deals
Log-In
Search

>> PODCAST: Start Small, Start Slowly: A Primer on Options Education <<

content-search-index Tag: SAVA SAVA 5 SEARCH RESULTS FOR: "Tag: SAVA"

REFINE YOUR SEARCH

REFINE YOUR SEARCH:

ARTICLES/BLOGS

2022(1)

2021(4)

CATEGORIES

5-Minute Market Rundown(1)

Buzz Stocks(4)

Intraday Option Activity(2)

Fresh Crop of Concerns Surrounding Alzheimer's Drug Sinks SAVA

https://www.schaeffersresearch.com/content/news/2022/04/19/fresh-crop-of-concerns-surrounding-alzheimers-drug-sink-sava

4/19/2022 10:19 AM

The shares of Cassava Sciences Inc (NASDAQ:SAVA) are taking a drubbing this morning, last seen down 23.6% at $19.35, and set for their lowest open since January 2021. Weighing on the stock is a rece...

Cassava Stock Surges as Social Media Buzz Intensifies

https://www.schaeffersresearch.com/content/news/2021/12/21/cassava-stock-surges-as-social-media-buzz-intensifies

12/21/2021 10:14 AM

The shares of Cassava Sciences Inc (NASDAQ:SAVA) are surging before the bell, last seen up 33.6% at $49.13, as the heavily shorted stock gains popularity on social media this morning. SAVA has been m...

Stocks Heading Into Holiday Season With Record Highs

https://www.schaeffersresearch.com/content/news/2021/11/05/stocks-heading-into-holiday-season-with-record-highs

11/5/2021 4:12 PM

Stocks continued their run of near daily record highs heading into November, as investors digested a slew of economic updates and earnings reports. The Federal Reserve was once again in focus this w...

Cassava Sciences Stock Surges on Alzheimer's Article Update

https://www.schaeffersresearch.com/content/news/2021/11/04/cassava-sciences-stock-surges-on-alzheimers-article-update

11/4/2021 3:49 PM

Cassava Sciences Inc (NASDAQ:SAVA) is soaring today, up 46.1% to trade at $82.80 at last glance, after the company said the Journal of Neuroscience found no evidence of data manipulation in its 2012 a...

Biotech Stock Tries to Recover as Alzheimer's Drug Draws Questions

https://www.schaeffersresearch.com/content/news/2021/08/26/biotech-stock-tries-to-recover-as-alzheimers-drug-draws-questions

8/26/2021 9:29 AM

Cassava Sciences Inc (NASDAQ:SAVA) is up 4.1% at $84.16 this morning, in an attempt to bounce back from yesterday's news that its Alzheimer's drug was facing scrutiny. The stock plummeted 31.4% -- mar...

PEOPLE ALSO SEARCH FOR